The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration
A Prospective Cohort Clinical Trial Evaluating Age as a Risk Factor for Poor Outcomes of Bridge-Enhanced ACL Restoration (BEAR)
Sponsor: Miach Orthopaedics
Listed as NCT03348995, this NA trial focuses on Anterior Cruciate Ligament Injury and Anterior Cruciate Ligament Rupture and remains ongoing. Sponsored by Miach Orthopaedics, it has been updated 21 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
21 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting NA
-
Jun 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 16 earlier versions
-
Jun 2022 — Sep 2023 [monthly]
Recruiting NA
-
Feb 2022 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2022 — Feb 2022 [monthly]
Recruiting NA
-
Dec 2021 — Jan 2022 [monthly]
Recruiting NA
-
Nov 2021 — Dec 2021 [monthly]
Recruiting NA
-
Oct 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Jul 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
-
Mar 2019 — Jul 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Mar 2019 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Sep 2018 — Nov 2018 [monthly]
Withheld
-
Jun 2018 — Sep 2018 [monthly]
Withheld
-
Apr 2018 — Jun 2018 [monthly]
Withheld
Phase: NA → None
-
Dec 2017 — Apr 2018 [monthly]
Withheld NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Miach Orthopaedics
For direct contact, visit the study record on ClinicalTrials.gov .